Delivery Order SPE2DB24D3013-SPE2DB24FFHTX
Award Date
9/12/24
Potential Completion Date
9/13/24
Potential Value
$1.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order award by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML, a medical device, with a ceiling value of $20,876.64. The contract is a Firm Fixed Price Delivery Order with a performance period through May 23, 2025. This award is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML medical devices. The contract has a ceiling value of $26,650.12 and a period of performance through January 13, 2025. It is a firm-fixed-price delivery order contract, without any set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML medical devices. The award has a ceiling value of $18,482.84 and a completion date of June 14, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that provides a wide range of medical products, including specialty medications, generic...
This federal contract award, valued at $1,425.93, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML medical products. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML medical devices, with a ceiling value of $2,292.35 and a completion date of April 27, 2023. This contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,620.12, is a firm-fixed-price delivery order for the supply of GVOKE HYPOPEN 1-PK 1 MG/0.2 ML 0.2ML medical devices. The contract has an ultimate completion date of March 25, 2025 and was awarded on March 24, 2025. Amerisourcebergen is the prime contractor, and the contract was not set aside for any specific business type....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the procurement of GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML medical devices. The contract has a firm fixed price and a ceiling value of $1,270.29. It is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML, a medical product, with a ceiling value of $11,206.63 and a period of performance through February 25, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This is a delivery order award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,554.12 firm-fixed-price contract is for the supply of GVOKE HYPOPEN 1-PK 1 MG/0.2 ML 0.2ML, a medical product. The contract has an ultimate completion date of February 11, 2025. This award is under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a $2,296.02 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML medical device, which supports military healthcare programs globally. The contract has an ultimate completion date of March 7, 2025. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) that...